News

Company News

Jeffrey L. Saver to Chair Astrocyte Pharmaceuticals’ Clinical Advisory Board

Cambridge, MA, December 11, 2018 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, today announced that Jeffrey L. Saver, M.D., has joined the company’s Scientific Advisory Board and will chair the company’s Clinical Advisory Board. Astrocyte Pharmaceuticals is developing small molecule therapeutics for the treatment of brain injuries, including patients who have suffered a […]

0 comments

Astrocyte Pharmaceuticals Awarded $3M NIH Small Business Grant to Advance TBI and Concussion Therapeutic

Cambridge, MA, September 19, 2018 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that it has been awarded a $3 million Phase 2 Small Business Innovation Research (SBIR) Grant from the National Institute Of Neurological Disorders And Stroke (NINDS) of the National Institutes of Health (NIH).  The grant provides funding to advance […]

0 comments

Astrocyte Pharmaceuticals Awarded Alzheimer’s Disease Research Grant

Cambridge, MA, September 18, 2018 – Astrocyte Pharmaceuticals, Inc., a privately held pharmaceutical company, announced today that it has been awarded $287k Phase 1 Small Business Technology Transfer (STTR) Grant from the National Institutes of Health’s (NIH) National Institute On Aging (NIA).  The grant provides funding to further evaluate and advance its promising neuroprotectant drug […]

0 comments

In the Media

The Race Is on for a ‘Concussion Pill’ as New NFL Season Begins” article in the Bleacher Report by Mike Tanier.

Astrocyte mentioned in StatNews article “A Pill for Concussions Remains a Brain-Busting Challenge” by Cassandra Willyard.

“To Curb Brain Damage, Astrocyte Pharmaceuticals Energizes Cells” article in Xconomy by David Holley.

Company Profile published by Nature Biopharma Dealmakers in the September 2015 issue dedicated to Neuroscience companies and their research.

Pursuing Concussion’s Cure” article in the Mission magazine by Will Samsom

Article by San Antonio Business Journal previewing presentation at The Health Cell’s State of the Industry event

Coverage by International Innovation in the May 20th 2014 issue (Issue 142), “A Brainy Bunch (free registration required)

Coverage by CBS Dallas reporter Brian New

Developing innovative neuroprotection therapies for Traumatic Brain Injuries (TBI), concussions, stroke, and neurodegenerative disorders